The Microcirculation in Diabetes
1987; Wiley; Volume: 4; Issue: 3 Linguagem: Inglês
10.1111/j.1464-5491.1987.tb00861.x
ISSN1464-5491
Autores Tópico(s)Glaucoma and retinal disorders
ResumoDiabetic MedicineVolume 4, Issue 3 p. 189-196 The Microcirculation in Diabetes J. E. Tooke, J. E. Tooke Departments of Physiology and Endocrinology, Charing Cross and Westminster Medical School, London W6 8RF, UKSearch for more papers by this author J. E. Tooke, J. E. Tooke Departments of Physiology and Endocrinology, Charing Cross and Westminster Medical School, London W6 8RF, UKSearch for more papers by this author First published: May/June 1987 https://doi.org/10.1111/j.1464-5491.1987.tb00861.xCitations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ditzel J., Rooth G. The micro-angiopathy in diabetes mellitus. A concept regarding its mechanism of origin. Diabetes 1955; 4: 474–475. 2 Lestradet H., Papoz L., de Menibus Hellouin Cl et al. Long-term study of mortality and vascular complications in juvenile-onset (Type 1) diabetes. Diabetes 1981; 30: 175–179. 3 Barbosa J., Ramsey RC, Knobloch WH et al. Histocompatability antigen frequencies in diabetic retinopathy. Am J Ophthalmol 1980; 90: 148–153. 4 Bodansky HJ, Wolf E., Cudworth AG et al. Genetic and immunologic factors in microvascular disease in type 1 insulin-dependent diabetes. Diabetes 1982 31: 70–74. 5 Barnett AH, Mijovic C., Fletcher J., et al. Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. Br Med J 1984; 289: 943–945. 6 Cooper ME, Duff R., Buchanan R., et al. Low serum C4 concentrations and microangiopathy in type I and type II diabetes. Br Med J 1986; 292: 801. 7 Johnson PC. Review of previous studies and current theories of autoregulation. Cire Res 1964; suppl 1: 2–24. 8 Michel CC. Fluid movements through capillary walls. Handbook of Physiology, section 2 The Cardiovascular System, vol IV. Bethesda, Maryland: American Physiological Society, 1984; 375–409. 9 Starling EH. On the absorption of fluids from connective tissue spaces. J Physiol 1896; 19: 312–326. 10 Bungaard M., Frokjaer-Jensen J. Aspects of the ultrastructure of terminal blood vessels: a quantitative study of consecutive segments of the frog mesenteric microvasculature. Microvase Res 1982; 23: 1–30. 11 Curry FE, Michel CC. A fibre matrix model of capillary permeability. Microvasc Res 1980; 20: 96–99. 12 Taylor AE, Granger DN., Exchange of macromolecules across the microcirculation. Handbook of Physiology, section 2 The Cardiovascular System, vol IV. Bethesda, Maryland: American Physiological Society, 1984; 467–520. 13 Renkin EM. Relation of capillary morphology to transport of fluid and large molecules: a review. Acta Physiol Scand 1979; 463: 81–91. 14 Simionescu M. Simionescu N. Ultrastructure of the microvascular wall: functional correlations. Handbook of Physiology, section 2 The Cardiovascular System, vol IV. Bethesda, Maryland: American Physiological Society, 1984; 41–102. 15 Michel CC, Phillips ME. The effects of bovine serum albumin and a form of cationised ferritin upon molecular selectivity of the walls of single frog capillaries. Microvasc Res 1985; 29: 190–203. 16 Williamson JR, Kilo C. Capillary basement membranes in diabetes. Diabetes 1983; 32: 96–100. 17 Levick JR, Smaje LH. An analysis of the permeability of a fenestra. Microvasc Res 1987; (in press). 18 Murphy ME, Johnson PC. Possible contribution of basement membrane to the structural rigidity of blood capillaries. Microvasc Res 1975; 9: 242–245. 19 Parving H-H., Viberti GC, Keen H. et al. Haemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32: 943–949. 20 Tooke JE. Microvascular haemodynamics in diabetes mellitus. Clin Sci 1986; 70: 119–125. 21 Zatz R., Brenner BM. Pathogenesis of diabetic microangiopathy: The hemodynamic view. Am J Med 1986; 80: 443–453. 22 Kohner EM, Hamilton AM, Saunders SJ et al. The retinal blood flow in diabetes. Diabetologia 1975; 11: 27–33. 23 Christiansen JS, Gammelgaard J., Tronnier B. et al. Kidney function and size in diabetics, before and during initial insulin treatment. Kid Int 1982; 21: 683–688. 24 Christensen NJ. A reversible vascular abnormality associated with diabetic ketosis. Clin Sci 1970; 39: 539–548. 25 Watkins PJ, Edmonds ME. Sympathetic nerve failure in diabetes. Diabetologia 1983; 25: 73–77. 26 Leslie P., Jung RT, Isles TE et al. Effect of optimal glycaemic control with subcutaneous insulin infusion on energy expenditure in type 1 diabetes mellitus. Br Med J 1986; 293: 1121–1126. 27 Bulpitt CJ, Kohner EM, Dollery CT. Autoregulation in the retinal microcirculation. In Microcirculatory Approaches To Current Therapeutic Problems. J. Ditzel, DH Lewis (Eds). Basel: Karger, 1971, 95–100. 28 Ditzel J., Jaeger P., Kjaergaard JJ. Hemoglobin Alc and red cell oxygen releasing capacity in relation to early microvascular responses in ambulatory diabetics. Adv Microcirc 1979; 8: 1–13. 29 Christlieb AR, Janka H-V, Kraus B. et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976; 25: 260–274. 30 Kreisberg JI, Patel PY. The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukotrienes Med 1983; 11: 431–442. 31 Sandahl-Christiansen J., Gammelgaard J., Frandsen M. et al. Kidney function and size in Type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week. Diabetologia 1982; 22: 333–337. 32 Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Invest 1971 28: 91–100. 33 Jensen PK, Blaehr H., Sandahl-Christiansen KS, Parving H-H. The effect of strict metabolic control on renal function in short-term streptozotocin diabetic rats. Diabetologia 1984; 27: 249, 292A (abstract). 34 Blatherwick NR, Medlar EM. Chronic nephritis in rats fed high protein diets. Arch Int Med 1937; 59: 572–596. 35 Dworkin LD, Hostetter TH, Rennke HG, Brenner BM. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 1984; 73: 1448–1461. 36 Berkman J., Rifkin H. Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metab Clin Exp 1973; 22: 715–222. 37 Wen SF, Bennel NM, Morthy AV. Effects of low protein feeding on experimental diabetic nephropathy. Kid Int 1985; 27: 252. 38 Zatz R., Meyer TW, Dunn BR et al. Lowering of arterial pressure limits glomerular hypertension and albuminuria in experimental diabetes. Proc Am Soc Nephrol 1984; 154A (abstract). 39 Behrendt T., Duane TD. Unilateral complications in diabetic retinopathy. Trans Am Acad Ophthalmol Otol 1970; 74: 28–32. 40 Tooke JE. A capillary pressure disturbances in young diabetics. Diabetes 1980; 29: 815–819. 41 Rayman G., Williams S., Hassan A. et al. Capillary hypertension and overperfusion in the feet of young diabetics. Diabetic Med 1985; 2: 304A, A30 (abstract). 42 Henricksen O., Nielsen SL, Paaske WP, Sejrsen P. Autoregulation of blood flow in human cutaneous tissue. Acta Physiol Scand 1973; 97: 377–384. 43 Henricksen O. Local nervous mechanism in regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand 1976; 97: 385–391. 44 Vracko R. Skeletal muscle capillaries in diabetics. Circulation 1970; 41: 271–283. 45 Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. Diabetes 1983; 32: (suppl 2): 64–78. 46 Kohner EM, Hamilton AM, Saunders SJ et al. The retinal blood flow in diabetes. Diabetologia 1975; 11: 27–33. 47 Bresnick GH, de Venecia G., Myers EL et al. Retinal ischaemia in diabetic retinopathy. Arch Ophthalmol 1975; 93: 1300–1310. 48 Megibow RS, Megibow SJ, Pollack H. et al. The mechanism of accelerated peripheral vascular sclerosis in diabetes mellitus. Am J Med 1953; 15: 322–329. 49 Mendlowitz M., Grossman EB, Alpert S. Decreased hallucal circulation, an early manifestation of vascular disease in diabetes mellitus. Am J Med 1953; 15: 316–321. 50 Ewald U., Tuvemo T., Rooth G. Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode. Lancet 1981; i: 1287–1288. 51 Rayman G., Williams SA, Spencer PD et al. Impaired microvascular hyperaemic response to minor skin trauma in type 1 diabetes. Br Med J 1986; 292: 1295–1298. 52 Fagrell B., Hermansson I-L, Karlander S-G, Ostergren J. Vital capillary microscopy for assessment of skin viability and microangiopathy in patients with diabetes mellitus. Acta Med Scand 1984; 687: 25–28. 53 Parving H-H, Kastrup H., Smidt UM et al. Impaired autoregulation of glomerular filtration rate in Type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27: 247–252. 54 Sinclair SH, Grunwald JE, Riva CE et al. Retinal vascular autoregulation in diabetes mellitus. Ophthalmol 1964; 89: 748–750. 55 Faris I., Nielsen Vagn H., Henriksen O. et al. Impaired autoregulation of blood flow in skeletal muscle and subcutaneous tissue in long-term Type I (insulin-dependent) diabetic patients with microangiopathy. Diabetologia 1983; 25: 486–488. 56 Kastrup J., Norgaard T., Parving H-H et al. Impaired autoregulation of blood flow in subcutaneous tissue of long-term Type I (insulin-dependent) diabetic patients with microangiopathy: An index of arteriolar dysfunction. Diabetologia 1985; 28: 711–717. 57 Uitto J., Perejda AJ, Grant GA et al. Glycosylation of human glomerular basement membrane collagen. Connect Tissue Res 1982; 10: 45–54. 58 Williamson JR, Kilo C. Current status of capillary basement-membrane disease in diabetes mellitus. Diabetes 1977; 26: 65–73. 59 Rohrbach DH, Wagner CW, Star V., Martin GR. Alterations in the basement membrane (heparan sulphate) proteoglycan in diabetic mice. Diabetes 1982; 31: (suppl 2): 185–188. 60 Vracko R., Benditt EP. Capillary basal lamina thickening. Its relationship to endothelial cell death and replacement. J Cell Biol 1970; 47: 281–285. 61 Villaschi S., Johns L., Cirigliano M., Pietra GG. Binding and uptake of native and glycosylated albumin-gold complexes in perfused rat lungs. Microvasc Res 1986; 32: 190–199. 62 Moncada S., Vane JR. Prostacyclin (PGI2), the vascular wall and vasodilatation. In Mechanisms Of Vasodilatation. pps Basel: Karger, 1978, 117–121. 63 Furchgott RF. Role of the edothelium in responses of vascular smooth muscle. Cire Res 1983; 53: 557–573. 64 Dollery CT, Friedman LA, Hensby CN et al. Circulating prostacyclin may be reduced in diabetes. Lancet 1979; ii: 1365. 65 Johnson M., Harrison HE, Raftery AT, Elder JB. Vascular prostacyclin may be reduced in diabetes in man. Lancet 1979; i: 3225–3226. 66 Davis TME, Mitchell MD, Dornan TL, Turner RC. Plasma 6-keto-PGF1 α concentrations. Lancet 1980; i: 373. 67 Schultz-Ehrenburg U., Weindorf N. Function diagnostics of diabetic microangiopathy by TCPO2-stimulation tests. Int J Microcirc: Clin Exp 1986; 5: 201, M-27 (abstract). 68 Aanderud S., Krane H., Nordoy A. Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro from cultured human endothelial cells. Diabetologia 1985; 28: 641–644. 69 Almer L-O, Pandolli M. Fibrinolysis and diabetic neuropathy. Diabetes 1976; 25, suppl 2: 807–810. 70 Porta M., Townsend C., Clover GM et al. Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 1981; 20: 597–601. 71 Garner A. Pathology of diabetic retinopathy. Br Med Bul 1970; 26: 137–142. 72 Tilton RG, Faller AM, Burkhardt JK et al. Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients. Diabetologia 1985; 28: 895–900. 73 Michel CC, Moyses C. The measurement of fluid filtration in human limbs. In Clinical Investigation of the Microcirculation. Tooke and Smaje, (eds). Boston: Martinus Nijhoff, 1987; 103–126. 74 Parving H-H, Noer I., Deckert T. et al. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 1976; 12: 161–166. 75 Rayman G., Hassan AAK, Tooke JE. Blood flow in the skin of the foot related to posture in diabetes mellitus. Br Med J 1986; i: 87–90. 76 Tooke JE, Rayman G. Are diabetic capillaries really leaky? Int J Microcirc: Clin Exp 1986; 5: 127. 77 Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in Type I (insulin-dependent) diabetic patients with microalbuminura. Diabetologia 1986; 29: 282–286. 78 Parving H-H, Rasmussen Munkgaard S. Transcapillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics. Scand J Clin Lab Invest 1973; 32: 81–87. 79 Parving H-H, Kastrup J., Smidt UM. Reduced transcapillary escape of alb min during acute blood pressure-lowering in Type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1985; 28: 797–801. 80 Parving H-H, Smidt UM. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy. Diabetic Medicine 1986; 3: 312–315. 81 Trap-Jensen J., Alpert JS, del Rio G., Lassen NA. Capillary diffusion capacity for sodium in skeletal muscle in long-term juvenile diabetes. Acta Med Scand 1967; 476: 135–146. 82 Trap-Jensen J. Increased capillary permeability to I13 and Cr51-EDTA in the exercising forearm of the long-term diabetic. Clin Sci 1970; 39: 39–40. 83 Bollinger A., Frey J., Jager K. et al. Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Eng J Med 1982; 307: 1305–1310. 84 Vollenweider U., Schnewlin G., Zimmermann D. et al. Transcapillary diffusion of Na-Fluorescein at the forefoot in type 1 diabetics with differing disease duration. Angio Archiv 1986; 12: 26, 18 (abstract). 85 Barnes AJ, Locke P., Scudder PR et al. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet 1977; ii: 789–791. 86 McMillan DE, Utterback NG, La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978; 27: 895–901. 87 McMillan DE. Blood flow and diabetic microangiopathy. Viscositas 1979; 1 (2): 5–8. 88 Branemark P-I, Lander L., Fagerberg SE, Breine V. Studies in rheology of human diabetes mellitus. Diabetologia 1971; 7: 107–112. 89 Tooke JE, Milligan DW. Blood rheology in vivo: The role of the red cell, white cell and plasma viscosity. Clin Haemorheol 1987; (in press). 90 Colwell JA, Winocour PD, Halushka PV. Do platelets have anything to do with diabetic microvascular disease? Diabetes 1983; 2: 14–19. 91 Ditzel J., Standl E. The problem of tissue oxygenation in diabetes mellitus: Its relation to the early functional changes in the microcirculation of diabetic subjects. Acta Med Scand (suppl) 1975; 578: 49–58. 92 Jones AF, Jennings PE, Lunec J., Barnett AH. Free radicle reaction products in diabetes mellitus: relationship to microangiopathy. Clin Sci 1985; 9: 44P, 120. 93 Sebag J., McMeel JW. Diabetic retinopathy. Pathogenesis and the role of retina-derived growth factor in angiogenesis. Survey Opthalmol 1986; 30: 377–384. 94 Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307: 652–659. 95 Hoyer JR, Elema JD, Vernier RL. Unilateral renal disease in the rat. II. Glomerular mesangial uptake of colloidal carbon in unilateral aminonucleoside nephrosis and neprotoxic serum nephritis. Lab Invest 1976; 34: 250–255. 96 Fagrell B., Tooke J., Ostergren B. Vital capillaroscopy for evaluating skin microcirculation in humans. Prog Appl Microcirc 1984; 6: 129–140. 97 Colwell JA, Bingham SF, Abraira C. et al. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care 1986; 9 (2): 140–148. 98 Lithner F., Tornblom N. Gangrene localized to the feet in diabetic patients., Acta Med Scand 1984; 215: 75–79. 99 Parving H-H, Andersen AR, Smidt UM, Svendsen PAa. Early agressive antihypertensive treatment reduces rate of decline in renal function in diabetic nephropathy. Lancet 1983; 1: 1175–1178. 100 Dornan TL, Tattersall RB. Blind alleys in diabetes research: Muscle capillary basement membrane thickening: Marker of microvascular complications or false prophet? Diabetic Med 1986; 3: 413–418. Citing Literature Volume4, Issue3May/June 1987Pages 189-196 ReferencesRelatedInformation
Referência(s)